135 related articles for article (PubMed ID: 15875187)
61. Anticancer effects on TACC3 by treatment of paclitaxel in HPV-18 positive cervical carcinoma cells.
Yim EK; Tong SY; Ho EM; Bae JH; Um SJ; Park JS
Oncol Rep; 2009 Feb; 21(2):549-57. PubMed ID: 19148534
[TBL] [Abstract][Full Text] [Related]
62. A potential synergistic anticancer effect of paclitaxel and amifostine on endometrial cancer.
Dai D; Holmes AM; Nguyen T; Davies S; Theele DP; Verschraegen C; Leslie KK
Cancer Res; 2005 Oct; 65(20):9517-24. PubMed ID: 16230417
[TBL] [Abstract][Full Text] [Related]
63. Combination effects of SC144 and cytotoxic anticancer agents.
Oshima T; Cao X; Grande F; Yamada R; Garofalo A; Louie S; Neamati N
Anticancer Drugs; 2009 Jun; 20(5):312-20. PubMed ID: 19322070
[TBL] [Abstract][Full Text] [Related]
64. Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients.
Sonnemann J; Gänge J; Pilz S; Stötzer C; Ohlinger R; Belau A; Lorenz G; Beck JF
BMC Cancer; 2006 Jul; 6():183. PubMed ID: 16834771
[TBL] [Abstract][Full Text] [Related]
65. Differential proteomic profiling identifies novel molecular targets of paclitaxel and phytoagent deoxyelephantopin against mammary adenocarcinoma cells.
Lee WL; Wen TN; Shiau JY; Shyur LF
J Proteome Res; 2010 Jan; 9(1):237-53. PubMed ID: 19894775
[TBL] [Abstract][Full Text] [Related]
66. Difference in cytotoxicity of paclitaxel against neoplastic and normal cells.
Matsuoka H; Furusawa M; Tomoda H; Seo Y
Anticancer Res; 1994; 14(1A):163-7. PubMed ID: 7909417
[TBL] [Abstract][Full Text] [Related]
67. Cytotoxic activity of a new paclitaxel formulation, Pacliex, in vitro and in vivo.
Hassan S; Dhar S; Sandström M; Arsenau D; Budnikova M; Lokot I; Lobanov N; Karlsson MO; Larsson R; Lindhagen E
Cancer Chemother Pharmacol; 2005 Jan; 55(1):47-54. PubMed ID: 15565443
[TBL] [Abstract][Full Text] [Related]
68. Cytoprotective effects of amifostine and cysteamine on cultured normal and tumor cells treated with paclitaxel in terms of mitotic index and 3H-thymidine labeling index.
Ozcan Arican G
Cancer Chemother Pharmacol; 2005 Aug; 56(2):221-9. PubMed ID: 15838658
[TBL] [Abstract][Full Text] [Related]
69. [Effects of paclitaxel and gefitinib on the proliferation and cell cycle of human lung adenocarcinoma cell SPC-A1.].
Jia G; Zhang W; Zhou J; Zhu Z
Zhongguo Fei Ai Za Zhi; 2008 Jun; 11(3):339-44. PubMed ID: 20731930
[TBL] [Abstract][Full Text] [Related]
70. Sequence-dependent cytotoxicity of etoposide and paclitaxel in human breast and lung cancer cell lines.
Perez EA; Buckwalter CA
Cancer Chemother Pharmacol; 1998; 41(6):448-52. PubMed ID: 9554587
[TBL] [Abstract][Full Text] [Related]
71. In vitro schedule-dependent interaction between paclitaxel and cisplatin in human carcinoma cell lines.
Kano Y; Akutsu M; Tsunoda S; Suzuki K; Yazawa Y
Cancer Chemother Pharmacol; 1996; 37(6):525-30. PubMed ID: 8612305
[TBL] [Abstract][Full Text] [Related]
72. [The effects of taxol on different types of lymphoma cell lines].
Zhou X; Xu L; He K
Zhonghua Yi Xue Za Zhi; 2000 Jan; 80(1):62-5. PubMed ID: 11798740
[TBL] [Abstract][Full Text] [Related]
73. Fluoxetine Enhances Anti-tumor Activity of Paclitaxel in Gastric Adenocarcinoma Cells by Triggering Apoptosis and Necroptosis.
Khing TM; Po WW; Sohn UD
Anticancer Res; 2019 Nov; 39(11):6155-6163. PubMed ID: 31704843
[TBL] [Abstract][Full Text] [Related]
74. Ether lipids enhance the cytotoxic effect of teniposide and paclitaxel in liposomes against leukaemic cells in culture.
Lundberg BB
Anticancer Drug Des; 1997 Sep; 12(6):503-13. PubMed ID: 9311558
[TBL] [Abstract][Full Text] [Related]
75. Paclitaxel immunoconjugate for the specific treatment of ovarian cancer in vitro.
Jaime J; Pagé M
Anticancer Res; 2001; 21(2A):1119-28. PubMed ID: 11396150
[TBL] [Abstract][Full Text] [Related]
76. Administration sequence-dependent antitumor effects of paclitaxel and 5-fluorouracil in the human gastric cancer cell line MKN45.
Toiyama Y; Tanaka K; Konishi N; Mohri Y; Tonouchi H; Miki C; Kusunoki M
Cancer Chemother Pharmacol; 2006 Feb; 57(3):368-75. PubMed ID: 16075279
[TBL] [Abstract][Full Text] [Related]
77. Paclitaxel and vinorelbine cause synergistic increases in apoptosis but not in microtubular disruption in human lung adenocarcinoma cells (A-549).
Jung M; Grunberg S; Timblin C; Buder-Hoffman S; Vacek P; Taatjes DJ; Mossman BT
Histochem Cell Biol; 2004 Feb; 121(2):115-21. PubMed ID: 14745558
[TBL] [Abstract][Full Text] [Related]
78. In vitro schedule-dependent interaction between paclitaxel and SN-38 (the active metabolite of irinotecan) in human carcinoma cell lines.
Kano Y; Akutsu M; Tsunoda S; Mori K; Suzuki K; Adachi KI
Cancer Chemother Pharmacol; 1998; 42(2):91-8. PubMed ID: 9654107
[TBL] [Abstract][Full Text] [Related]
79. Intervention effects of nedaplatin and cisplatin on proliferation and apoptosis of human tumour cells in vitro.
Su XY; Yin HT; Li SY; Huang XE; Tan HY; Dai HY; Shi FF
Asian Pac J Cancer Prev; 2012; 13(9):4531-6. PubMed ID: 23167374
[TBL] [Abstract][Full Text] [Related]
80. Schedule dependence of the interaction of radiation and Taxol in HeLa cells.
Talwar N; Redpath JL
Radiat Res; 1997 Jul; 148(1):48-53. PubMed ID: 9216618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
